Eye protection in psoralen photochemotherapy
- 1 March 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 104 (3) , 295-300
- https://doi.org/10.1111/j.1365-2133.1981.tb00952.x
Abstract
The optical performance of some commercially-available tinted lenses [to prevent cataracts] is discussed. There is a wide variation in the UV absorbing power of sunglasses although adequate protection against solar UV-A can be achieved with some, but not all, polarizing material. The darkness of a tint is not an indication of its likely performance within the UV bands and it is possible that lenses could be produced that lacked any significant tint yet absorbed strongly throughout the UV region. [Oral psoralen photochemotherapy (PUVA) is now widely used for the treatment of human psoriasis and other skin diseases.].This publication has 7 references indexed in Scilit:
- A comment on the routine testing of sunglasses in photochemotherapyBritish Journal of Dermatology, 1980
- Potential Ocular Complications from PUVA Therapy and Their PreventionJournal of Investigative Dermatology, 1980
- Photoprotection of the eye in PUVA therapyBritish Journal of Dermatology, 1978
- UV-APublished by Springer Nature ,1978
- Photosensitization of the Eye by 8-methoxypsoralen**From the Departments of Dermatology and Pathology, Baylor College of Medicine, Houston, Texas.Journal of Investigative Dermatology, 1969
- Photosensitization of the Eye with MethoxsalenArchives of Ophthalmology (1950), 1961
- Photosensitization of the Eye with MethoxsalenArchives of Ophthalmology (1950), 1960